IP Library Patent Application 15963005
Patent Application
App. No. 15/963,005

Method for Treatment and Prevention of Biofilm Formation During Breast Augmentation Procedures

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/963,005
Abstract

The present disclosure provides methods and compositions for the treatment and prevention of infections and biofilm prevention during breast augmentation procedures. The present disclosure also provides methods and compositions for the prevention of anaplastic large-cell lymphoma following breast augmentation procedures. The present methods comprise providing a breast implant pocket at a surgical site in a patient and irrigating the pocket with a solution of hypochlorous acid. In some embodiments, the methods further comprise treating a breast implant with a solution of hypochlorous acid for a period of time prior to a breast augmentation procedure. Further provided are hypochlorous acid solutions useful in the aforementioned methods.

Claims (28)

1 . A method of treating or preventing bacterial biofilm formation during a breast augmentation surgical procedure comprising:

providing a breast implant pocket at a surgical site in a patient and

irrigating the pocket with a solution of hypochlorous acid.

2 . The method of claim 1 , wherein the method further comprises soaking a breast implant in a hypochlorous acid solution prior to inserting the implant into the pocket.

3 . The method of claim 2 , further comprising irrigating the surgical site with a solution of hypochlorous acid after inserting the implant into the pocket.

4 . The method of claim 1 , wherein the hypochlorous acid has a concentration of about 0.01% to about 0.1% in the solution.

5 . The method of claim 4 , wherein the concentration is about 0.01% to about 0.075%.

6 . The method of claim 4 , wherein the concentration is about 0.02% to about 0.05%.

7 . The method of claim 4 , wherein the concentration is about 0.02% to about 0.03%.

8 . (canceled)

9 . The method of claim 1 , wherein the bacterial biofilm is a Ralstonia pickettii biofilm.

10 . A method of treating or preventing a Ralstonia Pickettii infection during a breast augmentation procedure comprising:

providing a breast implant pocket at a surgical site in a patient and irrigating the pocket with a solution of hypochlorous acid.

11 . The method of claim 10 , wherein the method further comprises soaking a breast implant in a hypochlorous acid solution prior to inserting the implant into the pocket.

12 . The method of claim 10 , further comprising irrigating the surgical site with a solution of hypochlorous acid after inserting the implant into the pocket.

13 . The method of claim 10 , wherein the hypochlorous acid has a concentration of about 0.01% to about 0.1% in the solution.

14 . The method of claim 13 , wherein the concentration is about 0.01% to about 0.075%.

15 . The method of claim 13 , wherein the concentration is about 0.02% to about 0.05%.

16 . The method of claim 13 , wherein the concentration is about 0.02% to about 0.03%.

17 . (canceled)

18 . A method of preventing the occurrence of anaplastic large-cell lymphoma following a breast augmentation procedure comprising:

providing a breast implant pocket at a surgical site in a patient and

irrigating the pocket with a solution of hypochlorous acid.

19 . The method of claim 18 , wherein the method further comprises soaking a breast implant in a hypochlorous acid solution prior to inserting the implant into the pocket.

20 . The method of claim 19 , further comprising irrigating the surgical site with a solution of hypochlorous acid after inserting the implant into the pocket.

21 . The method of claim 18 , wherein the hypochlorous acid has a concentration of about 0.01% to about 0.1% in the solution.

22 . The method of claim 21 , wherein the concentration is about 0.01% to about 0.075%.

23 - 34 . (canceled)

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2019
From: MCLEMORE, JOHN C.
To: PHASE ONE HEALTH, LLC
Reel/Frame 048696/0731 →
COURT APPOINTMENT Recorded Mar 26, 2019
From: INTEGRATED HEALING TECHNOLOGIES, LLC
To: MCLEMORE, JOHN C.
Reel/Frame 048697/0451 →